Skip to main content
. 2017 Jun 11;2017:9264904. doi: 10.1155/2017/9264904

Table 2.

Median sCD30 levels according to demographic characteristics of kidney allograft recipients at baseline.

Patient's characteristics n Pretransplant sCD30 P value n Posttransplant sCD30 P value
Age 21–40 (n = 23) 54.8 (36.9–96.6) 0.151 21–39 (n = 17) 21.4 (15.7–40.1) 0.817
>40 (n = 22) 42.0 (30.8–60.2) >39 (n = 16) 23.3 (14.8–37.5)
Gender Female (n = 20) 42.1 (29.1–71.2) 0.595 Female (n = 17) 26.6 (21.2–39.7) 0.260
Male (n = 25) 51.6 (36.2–64.2) Male (n = 16) 18.4 (12.9–38.8)
Donor source Living (n = 6) 85.6 (40.9–159.9) 0.038 Living (n = 4) 39.4 (30.3–45.0) 0.133
Deceased (n = 39) 48.3 (27.3–64.2) Deceased (n = 29) 21.4 (13.4–37.6)
Donor age 17–38 (n = 22) 54.8 (36.2–70.6) 0.960 17–39 (n = 17) 21.4 (13.4–40.1) 0.709
>38 (n = 23) 45.0 (29.7–79.5) >39 (n = 16) 25.1 (15.9–38.7)
Primary disease GN (n = 37) 51.0 (30.8–70.7) 0.782 GN (n = 28) 22.2 (14.6–38.7) 0.643
non-GN (n = 8) 45.8 (38.8–78.4) non-GN (n = 5) 23.5 (16.1–45.3)
Dialysis modality HD (n = 42) 50.2 (30.8–70.7) 0.814 HD (n = 30) 21.4 (13.4–37.6) 0.075
PD (n = 3) 40.9 (40.1–88.5) PD (n = 3) 44.8 (34.0–52.9)
Dialysis duration ≤18 m (n = 22) 50.6 (32.2–71.7) 0.711 <18 m (n = 16) 30.3 (19.2–42.5) 0.146
>18 m (n = 23) 48.3 (30.8–70.6) ≥18 m (n = 17) 19.9 (12.4–28.0)
Pregnancies Yes (n = 5) 60.2 (40.9–70.7) 0.661 Yes (n = 4) 27.7 (16.5–45.4) 0.730
No (n = 40) 48.9 (31.5–71.1) No (n = 29) 23.1 (15.7–39.7)
Transfusions Yes (n = 8) 47.5 (42.0–58.2) 0.988 Yes (n = 7) 23.5 (15.7–39.7) 0.682
No (n = 37) 51.0 (27.3–72.6) No (n = 26) 22.2 (13.4–40.1)
Previous transplants Yes (n = 2) 57.6 (51.0–64.2) 0.618 Yes (n = 2) 20.6 (13.4–27.8) 0.689
No (n = 43) 48.3 (30.8–71.7) No (n = 31) 23.1 (15.7–40.1)
Anti-CD25 antibodies Yes (n = 36) 48.9 (29.1–67.4) 0.567 Yes (n = 27) 21.4 (13.4–37.4) 0.089
No (n = 9) 51.6 (40.1–72.6) No (n = 6) 46.0 (23.5–50.7)

sCD30: soluble CD30; GN: glomerulonephritis; HD: hemodialysis; PD: peritoneal dialysis; m: months; n: number of patients investigated. Median (interquartile range); P values: significance of differences between subgroups of patients.